APA (7th ed.) Citation

Hasani-Ranjbar, S., Jouyandeh, Z., Qorbani, M., Hemmatabadi, M., & Larijani, B. (2012). The effect of semelil (angipars®) on bone resorption and bone formation markers in type 2 diabetic patients. DARU: Journal of Pharmaceutical Sciences, 20, 1. https://doi.org/10.1186/2008-2231-20-84

Chicago Style (17th ed.) Citation

Hasani-Ranjbar, Shirin, Zahra Jouyandeh, Mostafa Qorbani, Mahbubeh Hemmatabadi, and Bagher Larijani. "The Effect of Semelil (angipars®) on Bone Resorption and Bone Formation Markers in Type 2 Diabetic Patients." DARU: Journal of Pharmaceutical Sciences 20 (2012): 1. https://doi.org/10.1186/2008-2231-20-84.

MLA (9th ed.) Citation

Hasani-Ranjbar, Shirin, et al. "The Effect of Semelil (angipars®) on Bone Resorption and Bone Formation Markers in Type 2 Diabetic Patients." DARU: Journal of Pharmaceutical Sciences, vol. 20, 2012, p. 1, https://doi.org/10.1186/2008-2231-20-84.

Warning: These citations may not always be 100% accurate.